One Behavioral Provider’s Decision to Co-Develop Technology
Acclaim Autism’s COO Ryan Cox shares about his team’s tech journey
2024
Read More
This Pill-Size Diagnostic Seeks to Prevent Thousands of Esophageal Cancer Deaths
Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be screened end up never being tested. Lucid Diagnostics is trying to solve this problem by selling a quick, office-based diagnostic. The post This Pill-Size Diagnostic Seeks to Prevent Thousands of Esophageal Cancer Deaths appeared…
Cortica Snags $80M to Make Autism Care for Children Less Fragmented
Cortica’s $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism Impact Fund. The post Cortica Snags $80M to Make Autism Care for Children Less Fragmented appeared first on MedCity News.
Coverage of Dental Services in Traditional Medicare
In Medicare Physician Fee Schedule Final Rules from recent years, the administration made changes to Medicare payment policies for certain dental services, in addition to other payment and policy changes. The 2023 rule clarified CMS’s interpretation of when medically necessary dental services can be covered and codified certain payment policies, and the 2023, 2024, and…
Dicen que los esfuerzos contra el fraude en ACA han dado resultados. Pero hay que estar alerta
Los cambios no autorizados en los planes médicos de la Ley de Cuidado de Salud a Bajo Precio (ACA) parecen haberse reducido en las últimas semanas: reguladores federales informaron que hay menos quejas de los consumidores. Los Centros de Servicios de Medicare y Medicaid (CMS), que supervisan ACA, atribuyen esta reducción a las medidas adoptadas…
FDA Nod for BridgeBio Brings New Competition to Blockbuster Pfizer Cardio Drug
BridgeBio Pharma claims its drug, Attruby, has an edge over a Pfizer drug as a treatment for cardiomyopathy caused by transthyretin-mediated amyloidosis. But new competition to both products could come soon from Alnylam Pharmaceuticals, now set to receive an FDA decision in this indication by late March. The post FDA Nod for BridgeBio Brings New…
Flatiron Exec Describes Broadening Scope of Research Using Real-World Data
Neal Meropol, M.D., Flatiron’s vice president of research oncology, says that having a broader array of consumers of Flatiron’s real-world data opens up avenues to many different types of research, including on health equity
What is HEMA?
The Pink Sheet reports on a new international health technology assessment (HTA) body: Health Economics Methods Advisory group (HEMA). The Health Economics Methods Advisory group (HEMA) is a new, independent group of health technology assessment agencies from the US, England and Canada that will work together to develop recommendations on adopting novel health economic methods…
The Case for a “Single Source of Truth” in Provider Credentialing
A single source for provider credentialing would involve creating a centralized, continuously updated database of credentialing information that could be accessed and trusted across the healthcare sector. While no such system exists today, it should be the goal, and here’s why. The post The Case for a “Single Source of Truth” in Provider Credentialing appeared…
CommonSpirit Forms Alliance With University of Utah Health
Patients at the five CommonSpirit hospitals in Utah will have access to the physicians and providers at University of Utah Health